73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c

Anti-anxiety drug may improve brain cancer survival chances

Anti-anxiety drug may improve brain cancer survival chancesbyFlinders UniversityGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A new study shows that cerebrospinal fluid reduces c
Talazoparib + enzalutamide beneficial in metastatic prostate cancer

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according

Talazoparib + enzalutamide beneficial in metastatic prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer (mCRPC), treatment with talazoparib (TALA) plus enzalutamide (ENZA) is better than placebo (PBO) plus ENZA, according
What Is B-Cell Lymphoma?

What Is B-Cell Lymphoma?

What Is B-Cell Lymphoma?ByCorey WhelanPublished on February 23, 2022Medically reviewed byGagandeep Brar, MDB-cell lymphoma is a type ofnon-Hodgkin's lymphoma (NHL). N

What Is B-Cell Lymphoma?

What Is B-Cell Lymphoma?ByCorey WhelanPublished on February 23, 2022Medically reviewed byGagandeep Brar, MDB-cell lymphoma is a type ofnon-Hodgkin's lymphoma (NHL). N
As cancer deaths decline, access to care remains a challenge in some US communities

As cancer deaths decline, access to care remains a challenge in some US communities

by Alex Osiadacz,Mayo ClinicCredit: Unsplash/CC0 Public DomainCancer remains the second-leading cause of death in the U.S., but the number of people dying from cancer continues to decline. In th

As cancer deaths decline, access to care remains a challenge in some US communities

by Alex Osiadacz,Mayo ClinicCredit: Unsplash/CC0 Public DomainCancer remains the second-leading cause of death in the U.S., but the number of people dying from cancer continues to decline. In th
WHO moves step closer to cheaper breast cancer treatment

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization

WHO moves step closer to cheaper breast cancer treatment

The World Health Organization has approved a biosimilar version of Trastuzumab—the drug used to treat breast cancer—that is generally 65 percent cheaper than the originalThe World Health Organization
Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w

Racial disparity in pro-metastatic tumor microenvironment among women with residual breast cancer after NAC

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResidual tumors from Black patients with estrogen receptor (ER)-positive/HER2-negative primary breast cancer treated w
Scientists find powerhouses that fight tumours from within

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "

Scientists find powerhouses that fight tumours from within

In recent years doctors have turned to a new treatment for cancer, immunotherapy, which works by leveraging the body's own immune system to fight tumoursLurking deep inside some tumours are "
Three-country study provides insights into oral HPV incidence and risks in men

Three-country study provides insights into oral HPV incidence and risks in men

byH. Lee Moffitt Cancer Center & Research InstituteElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA new study has u

Three-country study provides insights into oral HPV incidence and risks in men

byH. Lee Moffitt Cancer Center & Research InstituteElectron micrograph of a negatively stained human papilloma virus (HPV) which occurs in human warts. Credit: public domainA new study has u
Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w

Pembrolizumab With COPDAC-28 Consolidation Increases PET Negativity in Classical Hodgkin Lymphoma

August 29, 2023Kyle DohertyThe addition of pembrolizumab to COPDAC-28 consolidation may augment responses to treatment in pediatric and young adult patients with high-risk classical Hodgkin lymphoma w
Potential new treatment for angioimmunoblastic T-cell lymphoma

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from

Potential new treatment for angioimmunoblastic T-cell lymphoma

byUniversity of TsukubaCredit: AI-generated imageA type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from
Inequities seen in cancer treatment delay in patients with SARS-CoV-2

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom

Inequities seen in cancer treatment delay in patients with SARS-CoV-2

by Elana GotkineRace and ethnicity and area-level social determinants of health (SDOH) are associated with delayed or discontinued cancer treatment among patients with severe acute respiratory syndrom
What you need to know after a breast cancer diagnosis

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr

What you need to know after a breast cancer diagnosis

by Robin FosterBreast cancer strikes 1 in 8 women in the United States, but being diagnosed with the disease can still make you feel alone.To cope with such devastating news, breast cancer surgeons fr